PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
06-May-2025 Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer Lundbeck
06-May-2025 Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer Lundbeck
06-May-2025 Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell FactoryTM for CAR-T therapy manufacturing Astraveus
06-May-2025 Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy Angelini Ventures
06-May-2025 ENA Respiratory Appoints International Pharma Experts as Strategic Advisors to Support Development of INNA-051 Antiviral Host Defence Enhancer ENA Respiratory
02-May-2025 Alimentiv Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego
02-May-2025 CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy CSL Vifor
02-May-2025 PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference PureTech
02-May-2025 ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 ProQR
01-May-2025 First patient enrolled in Phase 1 clinical trial of Akiram’s cancer drug candidate AKIR001 Akiram Therapeutics
01-May-2025 PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference PureTech
01-May-2025 NICE recommends Yselty®▼ (linzagolix) for symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis[i] Theramex
30-Apr-2025 BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47) BlackfinBio
30-Apr-2025 CellProthera to Present ProtheraCytes® Clinical Data and Receive a Stem Cell Engineering Abstract Award for Phase I/IIb Results at ISCT 2025 Scientific Annual Meeting in New Orleans CellProthera
30-Apr-2025 CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy CSL Vifor and Travere Therapeutics
30-Apr-2025 Cycuria Therapeutics Launches with the Formation of a Distinguished Advisory Board and Significant Public Grant Funding Cycuria Therapeutics
30-Apr-2025 Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC Johnson & Johnson’s
30-Apr-2025 Novo Nordisk Foundation expands Challenge Programme outside of Denmark for the first time and significantly increases grants Novo Nordisk
30-Apr-2025 OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain OKYO Pharma
30-Apr-2025 Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France Olon Group